Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Digestive Disorders

EU Gastroenterology Partner

An Introduction to Digestive Disorders

Inflammatory bowel disease is a term used to describe chronic, relapsing inflammatory disorders of the digestive tract. The major types are ulcerative colitis, which causes inflammation in the colon, and Crohn’s disease, which may affect any part of the digestive tract, from mouth to anus. Symptoms include abdominal pain, blood in the stool, irregular bowel habits, weight loss and fatigue. Established treatment options are surgery, aminosalicylates, corticosteroids, immunomodulators and anti-TNFα inhibitors; however, many patients will fail to respond or become refractory to these therapies. Emerging therapies include anti-integrin therapy, JAK1 inhibitors, sphingosine-1-phosphate receptor modulators, stem-cell transplant and faecal microbiota transplant.

Our supporting partners do not constitute an endorsement of the content on this page.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career doctors ready to think beyond the bedside and explore the business of medicine.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

Prof. Paul Fockens, recipient of the 2024 UEG Lifetime Achievement Award, has profoundly shaped the field of gastrointestinal endoscopy. From pioneering techniques like endoscopic ultrasound to advancing colorectal cancer screening and minimally invasive surgeries, his transformative contributions have improved patient care globally. A dedicated mentor and leader, Prof. Fockens has also championed education and innovation through his work with UEG and beyond."

Mark CompleteCompleted
BookmarkBookmarked

Each year, the United European Gastroenterology (UEG) organisation awards a prestigious €50,000 Research Prize to recognise excellence in basic science, translational, or clinical research. This award supports future innovative scientific projects from inception to completion, emphasizing their transformative potential to enhance patient care. This year’s recipient, Dr. Enrique de-Madaria, Gastroenterologist and Coordinator of the Biliary-Pancreatic Unit at Dr. Balmis Hospital in Alicante, Spain, has been honoured for his groundbreaking work in fluid resuscitation for acute pancreatitis. Over the past decade, his multicentre studies—bolstered by national and international collaborations—have redefined clinical practice and established new standards of care.

Mark CompleteCompleted
BookmarkBookmarked

IgG4-RD is a rare, chronic, relapsing condition characterized by fibroinflammatory lesions rich in CD19+ B cells, which can damage multiple organ systems and lead to organ failure.1 With no approved therapies, glucocorticoids are the primary treatment, but their long-term use is associated with adverse effects and inadequate disease control.1

Mark CompleteCompleted
BookmarkBookmarked

New research presented at UEG Week 2024 has introduced a strategy that could considerably reduce the need for insulin therapy in patients with type 2 diabetes (T2D).¹ The study investigated a novel approach combining ReCET (Re-Cellularization via Electroporation Therapy) with the ...

Mark CompleteCompleted
BookmarkBookmarked

Eosinophilic oesophagitis (EoE) is a chronic, immune-mediated inflammatory disease of the oesophagus that is progressive in nature and increasingly prevalent worldwide.1  The condition is driven by antigen-induced type 2 inflammation, leading to the infiltration of eosinophils, which causes esophageal dysfunction and ...

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Efrem Eren, Dr Nirmala Gonsalves, Dr Jamal Hayat

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Professor Matthias Löhr, Dr Shounak Majumder

Watch expert faculty discuss how to diagnose and treat the gastrointestinal manifestations of IgG4-related disease

Load More...
Close Popup